Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing proprietary spherical nucleic acid (SNA™) technology, announced an upcoming poster presentation for its intratumoral product candidate, cavrotolimod (AST-008), at the 35th Anniversary Annual Meeting of the Society for Immunotherapy of Cancer (SITC), to be held virtually from November… Read More..

Novel hemostatic wound dressing provides distinctive features FRAMINGHAM, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced receipt of the CE (Conformité Européenne) mark for its first-in-class wound care… Read More..

New Website Offers More Comprehensive Understanding of PCG’s Value Proposition and Overall Client Benefits New York City, NY, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- PCG Advisory, Inc., a leading investor relations, strategic communications and cutting-edge digital marketing firm, today announced the launch of its new redesigned website,… Read More..